The new diagnosis method using nanobecon for colitis associated carcinoma

The new diagnosis method using nanobecon for colitis associated carcinoma - The new diagnosis method for colitis associated carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015493

Enrollment

Registered

2014-11-01

Start date

2014-11-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis Colon carcinoma

Interventions

Conventional historogical examaination New immunohistochemisty using nanobecon

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with colon carcinoma or ulcerative colitis

Exclusion criteria

Exclusion criteria: 1.Patients with severe ulcerative colitis 2.Patients concomitant with severe infection, heart failure, hepatic disorder, pulmonary disease, or CNS disease 3.Pregnant woman 4.Patients who did not agree with this study 5.Patients that physician determined inappropriate

Design outcomes

Primary

Measure	Time frame
The efficacy of new diagnosis method using nanobecon for colitis associated carcinoma	—

Countries

Japan

Contacts

Public ContactTakuya Yoshino

Kyoto Univeristy Hospital Gastroenterology and Hepatology

tyocci@kuhp.kyoto-u.ac.jp075-751-4319

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026